Source: The Pharmacogenomics Journal. Unidades: EERP, FMRP
Subjects: POLIMORFISMO, FÁRMACOS (SISTEMA CARDIOVASCULAR), HIPERTENSÃO NA GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZON, Marcelo Rizzatti et al. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, v. 17, n. 5, p. 427-434, 2017Tradução . . Disponível em: https://doi.org/10.1038/tpj.2016.35. Acesso em: 28 out. 2024.APA
Luizon, M. R., Palei, A. C. T., Belo, V. A., Amaral, L. M., Lacchini, R., Duarte, G., et al. (2017). Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, 17( 5), 427-434. doi:10.1038/tpj.2016.35NLM
Luizon MR, Palei ACT, Belo VA, Amaral LM, Lacchini R, Duarte G, Cavalli R de C, Sandrim VC, Tanus-Santos JE. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2017 ; 17( 5): 427-434.[citado 2024 out. 28 ] Available from: https://doi.org/10.1038/tpj.2016.35Vancouver
Luizon MR, Palei ACT, Belo VA, Amaral LM, Lacchini R, Duarte G, Cavalli R de C, Sandrim VC, Tanus-Santos JE. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2017 ; 17( 5): 427-434.[citado 2024 out. 28 ] Available from: https://doi.org/10.1038/tpj.2016.35